Related Experiment Video
Updated: May 23, 2026
04:48
A High-throughput Calcium-flux Assay to Study NMDA-receptors with Sensitivity to Glycine/D-serine and Glutamate
Published on: July 10, 2018
Interactions between NMDA and dopamine receptors: a potential therapeutic target
Min Wang1, Albert H Wong, Fang Liu
1Department of Neuroscience, Centre for Addiction and Mental Health, Canada; Division of Life Sciences, Komaba Organization for Educational Excellence, College of Arts and Sciences, University of Tokyo,Tokyo 153-8902, Japan.
Brain Research
|April 5, 2012
Summary
Targeting specific neurotransmitter pathways, like dopamine and glutamate receptors, may offer new treatments for brain disorders. Understanding receptor interactions, such as NMDA and dopamine receptors, is key to developing effective therapies.
Area of Science:
- Neuroscience
- Pharmacology
- Molecular Biology
Background:
- Post-synaptic neurotransmitter receptor malfunctions are linked to various pathologies.
- Current drug therapies often fail due to side effects from broad receptor suppression.
- Novel therapeutic strategies require selective targeting of specific post-synaptic pathways.
Purpose of the Study:
- To explore the interactions between NMDA glutamate receptors and dopamine D1/D2 receptors.
- To address the therapeutic potential of targeting receptor heteromers for neuropsychiatric disorders.
- To review the complex neuronal interactions between dopaminergic and glutamatergic systems.
Main Methods:
- Review of existing literature on dopamine and glutamate receptor systems.
- Analysis of neurobiological pathways involving NMDA, dopamine D1, and dopamine D2 receptors.
- Exploration of the concept of receptor heteromers as therapeutic targets.
Main Results:
- Dopamine and glutamate systems are implicated in numerous neuropsychiatric disorders.
- Interactions between NMDA receptors and dopamine D1/D2 receptors are crucial for brain function.
- Receptor heteromers represent a promising area for novel drug development.
Conclusions:
- Selective targeting of neurotransmitter receptor pathways is essential for effective treatment.
- Understanding receptor heteromers offers a new avenue for therapeutic intervention in brain disorders.
- Further research into dopamine-glutamate interactions can lead to innovative treatments.
More Related Videos
Related Concept Videos
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
01:26Neurochemical Transmission: Sites of Drug Action
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:25Adrenergic Agonists: Indirect-Acting Agents
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...